Cocrystal Pharma Files 8-K
Ticker: COCP · Form: 8-K · Filed: May 29, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Cocrystal Pharma filed a standard 8-K, no major news.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on May 29, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by Cocrystal Pharma, Inc. to the SEC, providing transparency on their regulatory and financial disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- May 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38418 (commission_file_number) — SEC File Number
- 35-2528215 (ein) — IRS Employer Identification No.
- 19805 N. Creek Parkway (address) — Principal executive offices
- Bothell, WA (location) — Principal executive offices
- 98011 (zip_code) — Principal executive offices
- (877) 262-7123 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of May 29, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is May 29, 2025.
In which U.S. state is Cocrystal Pharma, Inc. incorporated?
Cocrystal Pharma, Inc. is incorporated in Delaware.
What is the SEC file number for Cocrystal Pharma, Inc.?
The SEC file number for Cocrystal Pharma, Inc. is 001-38418.
What is the principal executive office address for Cocrystal Pharma, Inc.?
The principal executive office address is 19805 N. Creek Parkway, Bothell, WA 98011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Cocrystal Pharma, Inc. (COCP).